GNTA
Price
$3.80
Change
-$0.00 (-0.00%)
Updated
Aug 7 closing price
Capitalization
69.5M
ROQAF
Price
$0.02
Change
-$0.03 (-60.00%)
Updated
Jul 14 closing price
Capitalization
3.45M
Interact to see
Advertisement

GNTA vs ROQAF

Header iconGNTA vs ROQAF Comparison
Open Charts GNTA vs ROQAFBanner chart's image
Genenta Science SpA
Price$3.80
Change-$0.00 (-0.00%)
Volume$886
Capitalization69.5M
Roquefort Therapeutics
Price$0.02
Change-$0.03 (-60.00%)
Volume$1K
Capitalization3.45M
GNTA vs ROQAF Comparison Chart in %
Loading...
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROQAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNTA vs. ROQAF commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNTA is a Hold and ROQAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (GNTA: $3.80 vs. ROQAF: $0.02)
Brand notoriety: GNTA and ROQAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNTA: 6% vs. ROQAF: 131%
Market capitalization -- GNTA: $69.5M vs. ROQAF: $3.45M
GNTA [@Biotechnology] is valued at $69.5M. ROQAF’s [@Biotechnology] market capitalization is $3.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNTA’s FA Score shows that 0 FA rating(s) are green whileROQAF’s FA Score has 1 green FA rating(s).

  • GNTA’s FA Score: 0 green, 5 red.
  • ROQAF’s FA Score: 1 green, 4 red.
According to our system of comparison, both GNTA and ROQAF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNTA’s TA Score shows that 5 TA indicator(s) are bullish while ROQAF’s TA Score has 0 bullish TA indicator(s).

  • GNTA’s TA Score: 5 bullish, 3 bearish.
  • ROQAF’s TA Score: 0 bullish, 2 bearish.
According to our system of comparison, GNTA is a better buy in the short-term than ROQAF.

Price Growth

GNTA (@Biotechnology) experienced а -1.20% price change this week, while ROQAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNTA($69.5M) has a higher market cap than ROQAF($3.46M). GNTA YTD gains are higher at: -12.644 vs. ROQAF (-57.300).
GNTAROQAFGNTA / ROQAF
Capitalization69.5M3.46M2,012%
EBITDAN/AN/A-
Gain YTD-12.644-57.30022%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
GNTAROQAF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
20%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROQAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDUC1.32N/A
N/A
Educational Development Corp
AVO12.39-0.02
-0.16%
Mission Produce
WST237.28-1.11
-0.47%
West Pharmaceutical Services
TIL26.31-0.68
-2.52%
Instil Bio
JOBY18.93-0.56
-2.87%
Joby Aviation

GNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNTA has been loosely correlated with ROQAF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GNTA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNTA
1D Price
Change %
GNTA100%
N/A
ROQAF - GNTA
37%
Loosely correlated
N/A
TNFA - GNTA
28%
Poorly correlated
-5.84%
BCYC - GNTA
26%
Poorly correlated
-5.09%
PHIO - GNTA
25%
Poorly correlated
-3.43%
SRRK - GNTA
24%
Poorly correlated
-9.30%
More

ROQAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROQAF has been loosely correlated with GNTA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ROQAF jumps, then GNTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROQAF
1D Price
Change %
ROQAF100%
N/A
GNTA - ROQAF
36%
Loosely correlated
+0.53%
CRBP - ROQAF
22%
Poorly correlated
+2.36%
SVRA - ROQAF
21%
Poorly correlated
+1.48%
SKYE - ROQAF
21%
Poorly correlated
+2.64%
SNTI - ROQAF
6%
Poorly correlated
-1.74%
More